A comprehensive view of Investigational New Drug Application (INDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
FDA accepts Angion’s IND application for clinical development of biopharmaceutical ANG-3070 oral tyrosine kinase inhibitor to treat idiopathic pulmonary fibrosis; Angion to start enrollment in Phase 1B study, with 20 patients in crossover design trial
Published:
May 17, 2022
by GlobeNewswire
|
Aptar Pharma announces use of the VP3 multidose device as delivery system for Glenmark’s Ryaltris nasal spray, which is being developed for treatment of seasonal allergic rhinitis
Published:
January 27, 2022
by AptarGroup Inc.
|
BetterLife Pharma plans filing of an Investigational New Drug application for its psychedelic-based treatment for major depressive disorder; company plans to initiate clinical trials by Q3 of 2022
Published:
January 26, 2022
by Globe Newswire
|
Ask us about our R&D/Patents market view
Trending Chart
Interactive chart with headline count